This report presents a rare case of a 43-year-old man with unresectable combined hepatocellular-cholangiocarcinoma who, after undergoing transarterial chemoembolization, systemic chemotherapy, and stereotactic body radiation therapy, accepted curative resection and obtained an overall survival of 25 months to date. The case highlights the need for adaptable treatment regimens due to the tumor's components and underscores the importance of surgery for long-term success.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: